Skip to content

Assessment of Colonic Permeability by Confocal Laser Endomicroscopy

Combined Assessment of Colonic Permeability by Real Time Confocal Laser Endomicroscopy and Sucralose Absorption Test

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00883077
Enrollment
30
Registered
2009-04-17
Start date
2009-04-30
Completion date
2009-12-31
Last updated
2009-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory Bowel Disease, Irritable Bowel Syndrome, Ulcerative Colitis

Keywords

permeability, inflammatory bowel disease, confocal laser endomicroscopy, irritable bowel syndrome

Brief summary

The purpose of this study is to evaluate the efficacy of confocal laser endomicroscopy in assessment of colonic permeability against conventional sugar absorption test.

Detailed description

Increased intestinal permeability has been shown significant in many gastrointestinal diseases, including inflammatory bowel disease and recently irritable bowel syndrome. The conventional test methods of permeability is sugar absorption test which is neither reliable and practical. Confocal laser endomicrosopy is a newly developed device which allows in vivo and real time observation of gastrointestinal mucosa. In our preliminary study we found that the commonly used contrast agent, fluorescein sodium shew differences of leakage into colonic crypt lumen among different patients. The fluorescein leakage might be due to abnormal colonic permeability, so we planed to compare the fluorescein leakage under confocal laser endomicroscopy with conventional sucralose absorption test.

Interventions

None listed

Sponsors

Shandong University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients with history of ulcerative colitis * Bowel habits alterations meeting IBS diagnosis criteria and indications for colonoscopy investigation * Asymptomatic individuals for health surveillance or patients for follow up after polypectomy * Patients complained of hemafecia but colonoscopy revealed only haemorrhoid

Exclusion criteria

* Known cancers or abdominal surgery * Scheduled for endoscopic treatment * Alarm symptoms such as anaemia, gastrointestinal bleeding or obstruction, marked weight loss, abdominal mass * Under conditions such as: * ascites * jaundice * liver cirrhosis * impaired renal function * coagulopathy * fever * pregnancy * breastfeeding * Inability to provide informed consent * Known allergy to fluorescein sodium

Design outcomes

Primary

MeasureTime frame
Fluorescein leakage under confocal laser endomicroscopy observation of colonic mucosa.Within the 30 minutes after injection of fluorescein

Secondary

MeasureTime frame
Total sucralose excretion.Within the 24 hours after drinking of sucralose

Countries

China

Contacts

Primary ContactYanqing Li, PhD. MD.
qiluliyanqign@gmail.com86-531-8216923

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026